Drug Profile
Elgodipine
Alternative Names: IQB 875; IQB 875DLatest Information Update: 11 Nov 1998
Price :
$50
*
At a glance
- Originator IQB
- Developer Almirall-Prodesfarma; IQB
- Class Antihypertensives; Dihydropyridines; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Atherosclerosis; Coronary disorders; Essential hypertension; Heart failure
Most Recent Events
- 11 Nov 1998 Discontinued-Clinical for Essential hypertension (IV)
- 11 Nov 1998 Discontinued-III for Angina pectoris in France (Unknown route)
- 11 Nov 1998 Discontinued-III for Angina pectoris in Germany (Unknown route)